So what’s all the fuss about? – Interview, part 3

Q. I should imagine that the question, ‘Are we at the beginning of a golden age of healthcare?’ which is one of the questions that is expected to kick off the conference program, will generate a lot of interest at the conference. What does it take, to bring such a ‘golden age’ into being?

RAINER HERZOG, HIMSS EUROPE: Everyone is talking about this new golden era in medicine. But what I’m interested in – and I think this conference will help answer this – is what this means for the patient! Is it the ‘second shoot to the moon’, as an ex-president once referred to it? If it is, then of course, that’s a very exciting thing! But we also need to explore what it takes to implement Big Data – not just from a change point of view, but from a delivery-of-care point of view – and then, of course you’re into genomics, personalized medicine, population health management, risk stratification…

We need to ask ourselves, is this really the big breakthrough for the patient that everyone’s expecting? And, if so, how can we make sure that it materializes?

MATTHIEU-P. SCHAPRANOW, HPI: Yes. Big Data is not just a theory anymore! It’s about the practical application. And so it’s important to have these real-world examples so that people can say, ‘Ahah, so Big Data’s not just about buzzwords any more – it’s about data analysis at our fingertips… we can really begin to use this stuff now!’

And this is one of the reasons we picked the HPI as the venue for this event. So you’re here at the university campus – you can brainstorm about innovative ideas but you will also have hands-on experiences with latest advantages in life sciences and digital health.

FLORIAN SCHLEHOFER, HEALTHCAPITAL: It was absolutely amazing to see how engaged everyone – from HIMSS, HPI or the program board – was in the development of this program. I really want to thank all of them. These partners tried to create a program which shows the wide range of data-based applications in healthcare and to address the different stakeholders.

I am especially happy that we could also organize the regional-focused HealthCapital Sessions to showcase Berlin-Brandenburg´s research activities, start-ups, companies and initiatives in the field of Big Data in Medicine. With our selection we demonstrate that Big Data is not only a buzz word in the German capital region. No, it has reached entrepreneurs, companies and hospitals and is starting to engage the patient as well. In Berlin-Brandenburg, everyone is preparing for this new age of healthcare.